SYM vs. GNOM
SYM (Symbotic Inc) is a stock, while GNOM (Global X Genomics & Biotechnology ETF) is Health & Biotech Equities fund tracking the Solactive Genomics Index. Over the past 5 years, SYM returned 31.12%/yr vs -11.06%/yr for GNOM. At a 0.26 correlation, their price movements are largely independent.
Performance
SYM vs. GNOM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SYM achieves a -35.18% return, which is significantly lower than GNOM's 14.90% return.
SYM
- 1D
- -4.05%
- 1M
- -28.61%
- YTD
- -35.18%
- 6M
- -34.45%
- 1Y
- 17.27%
- 3Y*
- -0.80%
- 5Y*
- 31.12%
- 10Y*
- —
GNOM
- 1D
- 0.90%
- 1M
- 12.22%
- YTD
- 14.90%
- 6M
- 11.42%
- 1Y
- 61.83%
- 3Y*
- 2.88%
- 5Y*
- -11.06%
- 10Y*
- —
SYM vs. GNOM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
SYM Symbotic Inc | -35.18% | 150.95% | -53.81% | 329.90% | 19.40% | -3.38% |
GNOM Global X Genomics & Biotechnology ETF | 14.90% | 18.65% | -15.99% | -8.63% | -36.27% | -6.82% |
Correlation
The correlation between SYM and GNOM is 0.37, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.37 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.37 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Mar 9, 2021 | 0.26 |
The correlation between SYM and GNOM shifts across timeframes, from 0.26 (all time) to 0.37 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SYM vs. GNOM — Risk / Return Rank
SYM
GNOM
SYM vs. GNOM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Symbotic Inc (SYM) and Global X Genomics & Biotechnology ETF (GNOM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SYM | GNOM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.08 | ||
| Sortino ratioReturn per unit of downside risk | -2.14 | ||
| Omega ratioGain probability vs. loss probability | 1.12 | 1.36 | -0.24 |
| Calmar ratioReturn relative to maximum drawdown | 0.31 | 3.42 | -3.11 |
| Martin ratioReturn relative to average drawdown | 0.58 | 9.81 | -9.23 |
Loading charts...
Drawdowns
SYM vs. GNOM - Drawdown Comparison
The maximum SYM drawdown since its inception was -72.46%, roughly equal to the maximum GNOM drawdown of -75.00%. Use the drawdown chart below to compare losses from any high point for SYM and GNOM.
Loading charts...
Drawdown Indicators
| SYM | GNOM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -72.46% | -75.00% | +2.54% |
Max Drawdown (1Y)Largest decline over 1 year | -55.82% | -18.17% | -37.65% |
Max Drawdown (3Y)Largest decline over 3 years | -72.46% | -44.24% | -28.22% |
Max Drawdown (5Y)Largest decline over 5 years | -72.46% | -72.29% | -0.17% |
Current DrawdownCurrent decline from peak | -55.82% | -52.52% | -3.30% |
Average DrawdownAverage peak-to-trough decline | -28.23% | -40.63% | +12.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 29.68% | 6.32% | +23.36% |
Volatility
SYM vs. GNOM - Volatility Comparison
Symbotic Inc (SYM) has a higher volatility of 18.00% compared to Global X Genomics & Biotechnology ETF (GNOM) at 9.34%. This indicates that SYM's price experiences larger fluctuations and is considered to be riskier than GNOM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SYM | GNOM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.00% | 9.34% | +8.66% |
Volatility (6M)Calculated over the trailing 6-month period | 42.84% | 20.57% | +22.27% |
Volatility (1Y)Calculated over the trailing 1-year period | 88.18% | 27.29% | +60.89% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 104.28% | 33.68% | +70.60% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 101.35% | 34.17% | +67.18% |
Dividends
SYM vs. GNOM - Dividend Comparison
SYM has not paid dividends to shareholders, while GNOM's dividend yield for the trailing twelve months is around 1.20%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
GNOM Global X Genomics & Biotechnology ETF | 1.20% | 1.37% | 0.00% | 0.00% | 0.00% | 0.03% | 0.14% |
SYM Symbotic Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
SYM and GNOM have a correlation of 0.37, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SYM has higher volatility (18.00%) compared to GNOM (9.34%). In terms of maximum drawdown, SYM dropped -72.46% vs GNOM's -75.00%.
GNOM currently has the higher Sharpe Ratio (2.28 vs 0.20), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SYM and GNOM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer